Skip to content

Explore dapagliflozin in symptomatic heart failure with reduced ejection fraction and Type 2 Diabetes

When
Thursday, May 13th 2021
7:30 PM - 9:00 PM
Where
Online
Cost
Free
Webinar with Dr Ted Wu and Prof Andrew Sindone introducing the DAPA-HF study and the evidence for Forxiga (dapagliflozin) for the treatment of symptomatic heart failure with reduced ejection fraction in adults with or without t2d. Also looks at the evidence beyond HbA1c in Type 2 Diabetes.
Health Professionals, stay up to date with the latest PHN news in your region
Subscribe to our newsletter